Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWPP Regulatory News (WPP)

Share Price Information for WPP (WPP)

Share Price is delayed by 15 minutes
Get Live Data
276.70    5.40 (1.99%)
Bid:
276.50
Ask:
276.70
Spread: 0.20 (0.072%)
Market Cap: £2.98b
WPP Live PriceLast checked at - London Stock Exchange

Intraday WPP Share Chart

Acquisition

7 Mar 2023 07:00

RNS Number : 0561S
WPP PLC
07 March 2023
Β 

Β 

FOR IMMEDIATE RELEASE

7 March 2023

Β 

WPP PLC ("WPP")

Β 

WPP acquires German healthcare specialist 3K Communication

Β 

Frankfurt-based 3K will join WPP's Hill+Knowlton Strategies, advancing the company's growth in the global healthcare sector

Β 

WPP announces today that it has acquired 3K Agentur fΓΌr Kommunikation (3K), one of the leading healthcare specialist PR agencies in Germany. 3K will become part of the Hill+Knowlton Strategies (H+K) global network, strengthening its healthcare presence in Europe and expanding its operations in Germany.

Founded 25 years ago, 3K is known for its expertise in healthcare, biopharmaceuticals, and related sciences, working with some of the world's most notable global pharmaceutical companies, consumer health brands, and local biotech start-ups.

The addition of 3K aligns with WPP's strategic focus on healthcare and marks the company's continued investment in Germany. In the second half of 2022, WPP appointed Wendy Lund as Chief Client Officer for Health & Wellness and FM Schmidt as WPP's first President of the German market.Β 

The acquisition is also the latest milestone in H+K's ongoing transformation. The agency has grown more than 25% over the last two years, expanding its global leadership team - including Brenna Terry as Global Chair of Healthcare - and acquiring the JeffreyGroup in Latin America.

AnnaMaria DeSalva, Global Chairman and CEO of Hill+Knowlton Strategies, said: "Healthcare is in a perpetual cycle of growth and transformation, demanding superior communication and stakeholder strategies. Hill+Knowlton has a large role to play in this dynamic market. The addition of 3K will meaningfully strengthen our international capability in healthcare, and I am delighted to welcome them to the H+K family."

Ruth Bastuck, Founder and Managing Director of 3K, said: "I'm incredibly proud of what we have successfully built at 3K over the past 25 years, but I am equally excited for our future with Hill+Knowlton. Healthcare is such an important component of H+K's global strategy, and we could not have found a better fit, culturally, strategically, or operationally. We are equally dedicated to shaping excellent medical-to-human interactions. Tapping into the diverse resources and global reach of the H+K and WPP networks will create many exciting new opportunities for both our clients and our employees."

Mark Read, CEO of WPP, said: "Amid today's dynamic macroeconomic conditions we have seen great resilience and growth in the healthcare sector, as well as across our own PR businesses. Germany is our third largest market, and the addition of 3K to Hill+Knowlton's growing portfolio further strengthens WPP's global healthcare offer to clients."

3K becomes the latest in a series of acquisitions - including FΔ“nom Digital, Diff, Passport, Newcraft and Corebiz in the last six months alone - that form part of WPP's accelerated growth strategy and focused M&A approach to continue to build on the company's core capabilities.

Β 

ENDS

Β 

Further information:

Louise Lacourarie, WPP

+44 (0)20 7282 4600 / +44 7741 360931

louise.lacourarie@wpp.com

Β 

Sarah Brandon, Hill+Knowlton

+1 416 413 4773

sarah.brandon@hkstrategies.com

Β 

About WPP WPP is the creative transformation company. We use the power of creativity to build better futures for our people, planet, clients and communities. For more information, visitΒ www.wpp.com.

Β 

About Hill+Knowlton

Hill+Knowlton Strategies, Inc. is an international communications consultancy, providing services to local, multinational, and global clients. H+K operates more than 70 offices in nearly 40 countries worldwide, as well as an extensive associate network, delivering award-winning campaigns to clients across all sectors and disciplines and with a focus on continued innovation for the industry. Headquartered in New York, the firm is part of WPP, one of the world's largest communications services groups. For more information about H+K, clickΒ here, follow us on TwitterΒ here, like us on FacebookΒ here, and follow us on LinkedInΒ here.

Β 

About 3K

Founded in 1998, 3K is one of the leading healthcare PR agencies in Germany, helping clients translate complex issues in healthcare and science into innovative formats, bringing products, brands and companies into the conversation. http://www.3k-kommunikation.de/

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ACQEAKDKELKDEFA
Date   Source Headline
7th Nov 20223:47 pmRNSNotification of Major Holdings
4th Nov 20227:00 amRNSTransaction in Own Shares
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20221:19 pmRNSTotal Voting Rights and Capital
1st Nov 20227:00 amRNSTransaction in Own Shares
31st Oct 20227:00 amRNSTransaction in Own Shares
28th Oct 20227:00 amRNSTransaction in Own Shares
27th Oct 20227:00 amRNSTransaction in Own Shares
26th Oct 20227:00 amRNSThird Quarter Trading Update
6th Oct 20221:30 pmRNSAcquisition
5th Oct 20229:00 amRNSNotification of Trading Update
3rd Oct 202211:24 amRNSTotal Voting Rights and Capital
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20227:00 amRNSTransaction in Own Shares
22nd Sep 20227:00 amRNSTransaction in Own Shares
21st Sep 20222:15 pmRNSAcquisition
21st Sep 20227:00 amRNSTransaction in Own Shares
19th Sep 20227:00 amRNSTransaction in Own Shares
16th Sep 20227:00 amRNSTransaction in Own Shares
15th Sep 20227:00 amRNSTransaction in Own Shares
14th Sep 20227:00 amRNSTransaction in Own Shares
13th Sep 20227:00 amRNSTransaction in Own Shares
12th Sep 20227:00 amRNSTransaction in Own Shares
8th Sep 20228:00 amRNSShare buyback programme
1st Sep 20221:27 pmRNSTotal Voting Rights and Capital
1st Sep 20227:00 amRNSAcquisition
8th Aug 20225:29 pmRNSDirector / PDMR Transaction notification
5th Aug 20227:00 amRNS2022 Interim Results
1st Aug 202210:37 amRNSTotal Voting Rights and Capital
20th Jul 20225:12 pmRNSNotice of 2022 Interim Results
18th Jul 20227:00 amRNSAcquisition
7th Jul 20222:26 pmRNSNotification of Major Holdings
7th Jul 202212:18 pmRNSNotification of Major Holdings
1st Jul 20225:38 pmRNSTotal Voting Rights and Capital
1st Jul 20225:33 pmRNSNotification of Major Holdings
30th Jun 20227:00 amRNSAcquisition
1st Jun 202212:44 pmRNSTotal Voting Rights and Capital
27th May 20227:00 amRNSTransaction in Own Shares
26th May 20222:19 pmRNSNotification of Major Holdings
26th May 20227:00 amRNSTransaction in Own Shares
25th May 202212:10 pmRNSNotification of Major Holdings
25th May 20227:00 amRNSTransaction in Own Shares
24th May 20225:11 pmRNSResults of AGM
24th May 20227:00 amRNSTransaction in Own Shares
23rd May 20227:00 amRNSTransaction in Own Shares
20th May 20227:00 amRNSTransaction in Own Shares
19th May 20227:00 amRNSTransaction in Own Shares
18th May 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.